About Oncology 2020
- Home |
- About Oncology 2020
The word onco means-mass, bulk or tumor. Logy means-study. Cancer has more than 100 different diseases and It can develop almost anywhere in the body. The oncology has three major areas medical, surgical and radiation. A medical oncologist treats cancer using chemotherapy, targeted therapy or immunotherapy. A surgical oncologist removes the tumor during surgery. A radiation oncologist treats cancer using radiation therapy.
Cells are the basic units that make up the human body. Cells grow and divide to make new cells as the body requirement. Cells die when they get too old. Then new cells take their place. If cells start to grow uncontrollably and these cells may form a mass called a tumor. A tumor can be cancer or beginning. Always cancer does not form a tumor. Breast cancer is one of the most common types of cancer in Paris. The next most common cancers are lung cancer, prostate cancer, and colorectal cancers. A person has more than one cancer at a time. Cancer can develop almost anywhere in the body. Cancer is one of the most common cause of death in France. In man, lung cancer is the main cause of death and women, it is breast cancer. Tobacco and cigarette smoking also cause of lung cancer. The two types of lung cancer are there 1-Small cell lung cancer(SCLC), 2-Non small cell lung cancer(NSCLC). Two types of breast cancer are there 1-Ductal carcinoma and 2-lobular carcinoma. Ductal carcinoma begins in the milk duct and it is the most common type
Many causes of cancer are their heavy alcohol consumption, excess body weight, physical inactivity, poor nutrition, etc. some cancers are preventable. Lung cancer affects the heart sometimes.
Learning is a never-ending process. Conferences are not just about discussion, but to connect people with people, people with ideas, and people with opportunities. The key motto of Hilaris Conferences is to unite the Energy of Like-Minded Individuals to mold the future of research which will shape the future of the world.
Hilaris Conferences is the key to unlock the doors of innovation. Hence, Hilaris Conferences will be a unique platform to sharpen your skill to achieve your goals. Diverse and innovative Conferences with a plethora of research topics will provide everyone a unique learning and career-building opportunities. Hilaris conference will rewrite your brain with new and innovative ideas which will help you to boost your self-Esteem and confidence.
There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among man.
In France, three million people have survived cancer. the disease has doubled in 45 years. In 2015, 385,000 new cases of cancer were recorded in France. IN 2015- 211,000 new cases in men and 174,000 cases in women (average age of 68-67). In France, 2007-2016, the new cases of cancer was estimated at 356,556 per year and the number of deaths between 2007-2014 was 152,556 per year. In 2008 about 12.7 million cases and 7.6million cancer deaths are estimated. 56% of the cases and 64% of the deaths in the economically developing world. Prostate cancer, today the most common tumor in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years old.
Most Technologically Advanced Cancer Centers in the World
International Oncology Drugs
The best cancer research academic institutions in the world